Published in Biol Reprod on December 06, 2012
Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol (2015) 0.85
Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model. J Infect Dis (2013) 0.84
IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells. Front Microbiol (2016) 0.80
How can we design better vaccines to prevent HIV infection in women? Front Microbiol (2014) 0.79
Mucins help to avoid alloreactivity at the maternal fetal interface. Clin Dev Immunol (2013) 0.77
New Systems for Studying Intercellular Interactions in Bacterial Vaginosis. J Infect Dis (2016) 0.77
The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal Fluid. PLoS One (2016) 0.77
Human three-dimensional endometrial epithelial cell model to study host interactions with vaginal bacteria and Neisseria gonorrhoeae. Infect Immun (2017) 0.75
Three-Dimensional Rotating Wall Vessel-Derived Cell Culture Models for Studying Virus-Host Interactions. Viruses (2016) 0.75
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature (2001) 25.15
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Mucin dynamics and enteric pathogens. Nat Rev Microbiol (2011) 4.23
Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci (2003) 3.52
Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J (2001) 3.18
Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev (2005) 3.01
Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci (2003) 2.78
Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol (2002) 2.19
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci U S A (2011) 2.14
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses. Proc Natl Acad Sci U S A (2009) 2.13
Mucin gene expression during differentiation of human airway epithelia in vitro. Muc4 and muc5b are strongly induced. Am J Respir Cell Mol Biol (1999) 2.10
In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr (2005) 1.99
Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol (2005) 1.83
Mucous glycoproteins: a gel of a problem. Essays Biochem (1985) 1.82
The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol (2002) 1.81
Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol Cell Proteomics (2007) 1.74
Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One (2010) 1.73
Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol (2011) 1.55
Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res (2010) 1.54
Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol (2008) 1.49
Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol (2006) 1.48
Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol (2010) 1.46
Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol (2011) 1.45
Characterization of Toll-like receptors in the female reproductive tract in humans. Hum Reprod (2005) 1.42
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract. Sex Transm Infect (2001) 1.39
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother (2006) 1.37
Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol (2002) 1.35
Muc1 mucins on the cell surface are adhesion sites for Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol (2001) 1.32
Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod (1997) 1.29
Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia. Biol Reprod (2011) 1.29
A Bayesian method for calculating real-time quantitative PCR calibration curves using absolute plasmid DNA standards. BMC Bioinformatics (2008) 1.26
Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol (2000) 1.25
Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun (2008) 1.22
Mucins of the human endocervix. Front Biosci (2001) 1.20
Release of membrane-associated mucins from ocular surface epithelia. Invest Ophthalmol Vis Sci (2008) 1.18
CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol (2009) 1.18
Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission. J Infect Dis (2001) 1.15
Innate immunity and disorders of the female reproductive tract. Reproduction (2008) 1.14
Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome Sci (2009) 1.10
Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol Hum Reprod (1999) 1.09
Purification of human midcycle cervical mucin and characterization of its oligosaccharides with respect to size, composition, and microheterogeneity. J Biol Chem (1981) 1.08
MUC4 and MUC5B transcripts are the prevalent mucin messenger ribonucleic acids of the human endocervix. Biol Reprod (1999) 1.07
Preconceptional antibiotic treatment to prevent preterm birth in women with a previous preterm delivery. Am J Obstet Gynecol (2006) 1.05
Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses. Antimicrob Agents Chemother (2009) 1.02
Pattern recognition via the toll-like receptor system in the human female genital tract. Mediators Inflamm (2010) 1.01
Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod (2009) 1.00
Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol (2011) 0.99
Mucin expression and function in the female reproductive tract. Hum Reprod Update (1999) 0.92
Culturing and applications of rotating wall vessel bioreactor derived 3D epithelial cell models. J Vis Exp (2012) 0.86
Primary human epithelial cell culture system for studying interactions between female upper genital tract and sexually transmitted viruses, HSV-2 and HIV-1. Methods (2011) 0.83
Transmembrane and truncated (SEC) isoforms of MUC1 in the human endometrium and Fallopian tube. Reprod Biol Endocrinol (2003) 0.82
Mucin functions and expression in mammalian reproductive tract tissues. Biochem Biophys Res Commun (1998) 0.80
Structural and ultrastructural parameters of the uterine cervix. Obstet Gynecol Surv (1982) 0.78
Cyclic changes in the surface structure of the cervix from the ewe as revealed by scanning electron microscopy. Tissue Cell (1979) 0.76
Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod (2005) 2.48
An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun (2004) 1.69
Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem (2005) 1.55
Quantification and comparison of toll-like receptor expression and responsiveness in primary and immortalized human female lower genital tract epithelia. Am J Reprod Immunol (2008) 1.49
Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol (2010) 1.46
Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun (2005) 1.41
CD1d degradation in Chlamydia trachomatis-infected epithelial cells is the result of both cellular and chlamydial proteasomal activity. J Biol Chem (2007) 1.30
A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proc Natl Acad Sci U S A (2011) 1.21
A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am J Reprod Immunol (2008) 1.20
Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine (2011) 1.07
Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun (2012) 1.02
Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod (2009) 1.00
Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix. J Reprod Immunol (2011) 0.99
Expression of CD1d and ligand-induced cytokine production are tissue specific in mucosal epithelia of the human lower reproductive tract. Infect Immun (2008) 0.97
Inhibition of indoleamine 2,3-dioxygenase activity by levo-1-methyl tryptophan blocks gamma interferon-induced Chlamydia trachomatis persistence in human epithelial cells. Infect Immun (2011) 0.93
An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clin Vaccine Immunol (2010) 0.91
Altered protein secretion of Chlamydia trachomatis in persistently infected human endocervical epithelial cells. Microbiology (2011) 0.88
Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection. Curr HIV Res (2012) 0.88
Culturing and applications of rotating wall vessel bioreactor derived 3D epithelial cell models. J Vis Exp (2012) 0.86
Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study. J Reprod Immunol (2013) 0.85
Chlamydia trachomatis immune evasion via downregulation of MHC class I surface expression involves direct and indirect mechanisms. Infect Dis Obstet Gynecol (2011) 0.85
Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine. PLoS One (2012) 0.84
The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin. BMC Immunol (2012) 0.84
Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells. Cytokine (2013) 0.83
Mucosal co-infections and HIV-1 transmission and pathogenesis. Curr HIV Res (2012) 0.75